Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Myriad Genetics, Inc. - Common Stock
(NQ:
MYGN
)
4.290
+0.090 (+2.14%)
Delayed Quote
Updated: 1:29 PM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Myriad Genetics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
October 08, 2026
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Therapeutics Stocks Q2 Highlights: Gilead Sciences (NASDAQ:GILD)
October 07, 2026
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Gilead Sciences (NASDAQ:GILD)...
Via
StockStory
Topics
Artificial Intelligence
Why Is Myriad Genetics (MYGN) Stock Soaring Today
October 02, 2026
What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 5% in the afternoon session after Craig-Hallum analyst John Wilkin rais...
Via
StockStory
1 Volatile Stock on Our Buy List and 2 We Question
October 02, 2026
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be...
Via
StockStory
3 Reasons MYGN is Risky and 1 Stock to Buy Instead
September 24, 2026
Over the past six months, Myriad Genetics’s stock price fell to $4.01. Shareholders have lost 13% of their capital, which is disappointing considering the S&...
Via
StockStory
Topics
Bankruptcy
Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV)
September 21, 2026
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at AbbVie (NYSE:ABBV) and its pe...
Via
StockStory
Topics
Artificial Intelligence
1 Unpopular Stock That Deserves Some Love and 2 We Turn Down
September 17, 2026
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...
Via
StockStory
Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial
September 16, 2026
From
Myriad Genetics, Inc.
Via
GlobeNewswire
2 Unprofitable Stocks to Research Further and 1 We Find Risky
September 15, 2026
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
Via
StockStory
Q2 Rundown: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs Other Therapeutics Stocks
September 09, 2026
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Vertex Pharmaceuticals (NASD...
Via
StockStory
Topics
Artificial Intelligence
Therapeutics Stocks Q2 Recap: Benchmarking Myriad Genetics (NASDAQ:MYGN)
September 07, 2026
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Myriad Genetics (NASDAQ:MYGN) and its peers. Over th...
Via
StockStory
Topics
Artificial Intelligence
Stocks making big moves yesterday: Myriad Genetics, Greenbrier, Tidewater, Strategy, and Charter
September 02, 2026
Check out the companies making headlines yesterday: Myriad Genetics (NASDAQ:MYGN): Genetic testing company Myriad Genetics (NASDAQ:MYGN) fell by 6.2% on Tues...
Via
StockStory
Topics
Economy
Why Myriad Genetics (MYGN) Stock Is Down Today
September 01, 2026
What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 6.2% in the afternoon session after Piper Sandler double-downgraded the s...
Via
StockStory
Q2 Earnings Highlights: Moderna (NASDAQ:MRNA) Vs The Rest Of The Therapeutics Stocks
August 27, 2026
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Moderna (NASDAQ:MRNA) and its peers. Over the next f...
Via
StockStory
Topics
Artificial Intelligence
Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference
August 27, 2026
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics and Moderna Shares Plummet, What You Need To Know
August 24, 2026
What Happened? A number of stocks fell in the afternoon session after shares across biotech and big pharma cooled further as traders continued to secure prof...
Via
StockStory
1 Small-Cap Stock with Promising Prospects and 2 That Underwhelm
August 18, 2026
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Via
StockStory
Topics
Artificial Intelligence
Q2 Rundown: Natera (NASDAQ:NTRA) Vs Other Biotechnology Stocks
August 17, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how biotechnology stocks f...
Via
StockStory
Topics
Artificial Intelligence
MYGN SHAREHOLDER ALERT: Myriad Genetics Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
August 13, 2026
From
Kirby McInerney LLP
Via
Business Wire
3 Healthcare Stocks with Open Questions
August 10, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...
Via
StockStory
MYGN Investors Have Opportunity to Join Myriad Genetics, Inc. Fraud Investigation with SBS Law
August 08, 2026
From
Schall, Brown & Schwartz LLP
Via
Business Wire
MYRIAD INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Myriad Genetics, Inc. on Behalf of Myriad Stockholders and Encourages Investors to Contact the Firm
August 07, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
MYGN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Myriad Genetics (MYGN)
August 05, 2026
From
Levi & Korsinsky, LLP
Via
Business Wire
Myriad Genetics Q2 Earnings Call Highlights
↗
July 31, 2026
Myriad Genetics (NASDAQ:MYGN) reported second-quarter 2026 revenue of $190.7 million, down 11% from a year earlier, as a 1% decline in total test volume and a 9% decrease in revenue per test weighed on...
Via
MarketBeat
Topics
Artificial Intelligence
Earnings
Top movers in Friday's session
↗
July 31, 2026
Via
Chartmill
Why Myriad Genetics (MYGN) Shares Are Falling Today
July 31, 2026
What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 46.1% in the afternoon session after the company reported disappointing s...
Via
StockStory
Topics
Artificial Intelligence
Top stock movements in today's session.
↗
July 31, 2026
Via
Chartmill
Gapping stocks in Friday's session
↗
July 31, 2026
Via
Chartmill
Friday's pre-market session: top gainers and losers
↗
July 31, 2026
Via
Chartmill
Thursday's after hours session: top gainers and losers
↗
July 30, 2026
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
